About Julius Knowles
Julius Knowles is a president and director at 65 Therapeutics.
Julius Knowles first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Julius Knowles in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Julius Knowles works with at each company, as listed on that company's latest Form D.
65 Therapeutics, Inc. · Form D/A, Jul 6, 2026
MC
Murthy Chavali
Director